👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Ascelia Pharma AB (ACELP)

Stockholm
Currency in SEK
2.185
-0.035(-1.80%)
Closed
ACELP Scorecard
Full Analysis
Suffers from weak gross profit margins
Fair Value
Day's Range
2.1552.235
52 wk Range
1.81212.438
Bid/Ask
2.185 / 2.185
Prev. Close
2.185
Open
2.22
Day's Range
2.155-2.235
52 wk Range
1.812-12.438
Volume
278,464
Average Volume (3m)
486,793
1-Year Change
-11.28%
Fair Value
Unlock
Fair Value Upside
Unlock
ACELP Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Ascelia Pharma AB Company Profile

Ascelia Pharma AB (publ), a biotech company, focuses on orphan oncology treatments in Sweden. The company identifies, develops, and commercializes novel drugs to address unmet needs for rare cancer conditions. It develops Orviglance, a novel non-gadolinium diagnostic drug, which is in Phase 3 trial for use in MRI-scans of the liver; and Oncoral, a novel oral irinotecan chemotherapy tablet, that is in Phase 2 trial for the treatment of gastric cancer. Ascelia Pharma AB (publ) was incorporated in 1999 and is based in Malmö, Sweden.

Compare ACELP to Peers and Sector

Metrics to compare
ACELP
Peers
Sector
Relationship
P/E Ratio
−3.3x−1.9x−0.6x
PEG Ratio
−0.06−0.020.00
Price/Book
4.3x1.7x2.6x
Price / LTM Sales
-6.9x3.2x
Upside (Analyst Target)
311.9%117.0%49.1%
Fair Value Upside
Unlock27.1%7.2%Unlock

FAQ

What Is the Ascelia Pharma (ACELP) Stock Price Today?

The Ascelia Pharma stock price today is 2.185

What Stock Exchange Does Ascelia Pharma Trade On?

Ascelia Pharma is listed and trades on the Stockholm stock exchange.

What Is the Stock Symbol for Ascelia Pharma?

The stock symbol for Ascelia Pharma is "ACELP."

What Is the Ascelia Pharma Market Cap?

As of today, Ascelia Pharma market cap is 209.93M.

What is Ascelia Pharma Earnings Per Share?

The Ascelia Pharma EPS is -1.83.

What Is the Next Ascelia Pharma Earnings Date?

Ascelia Pharma will release its next earnings report on Nov 07, 2024.

From a Technical Analysis Perspective, Is ACELP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.